Stadtlanders Pharmacy

CDC HIV/STD/TB Prevention News Update

Tuesday, December 28, 1999
The CDC National Center for HIV, STD, and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases, and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Peer-Review Headlines

General Meadia


Peer-Review Headlines

Zoster Incidence in Human Immunodeficiency Virus Infected Hemophiliacs and Homosexual Men, 1984-1997

"Zoster Incidence in Human Immunodeficiency Virus Infected Hemophiliacs and Homosexual Men, 1984-1997" Journal of Infectious Diseases Online (12/99) Vol. 180, No. 6, P. 1784; Engels, Eric A.; Rosenberg, Philip S.; Biggar, Robert J.; et al.
Investigators from the National Cancer Institute report declines in the incidence of zoster, a severe cutaneous eruption caused by varicella zoster virus, among HIV-infected hemophiliacs and homosexual men between 1984 and 1997. The researchers studied data for more than 1,200 individuals in the District of Columbia Gay Cohort Study and the Multicenter Hemophilia Cohort Study and identified a total of 174 zoster cases, for an average annual incidence of 2.5 percent. Incidence of the condition dropped about 9 percent annually during the 14 years of follow-up. The researchers note that "this decline was unexpected, because it occurred despite worsening in the immune status of subjects." They suggest that possible reasons for the drop include reporting artifacts, better clinical care, and the loss of zoster-susceptible individuals from the study group. Despite the declines, the researchers note that zoster is still a key issue. High-dose acyclovir prophylaxis can significantly reduce zoster incidence, and while the varicella zoster virus vaccine is also a possibility, its safety as a live virus vaccine in HIV-infected individuals is not known.


General Media

Vending Machines Enlisted in AIDS Fight

"Vending Machines Enlisted in AIDS Fight" New York Times (12/28/99) P. D7; Berger, Alisha
Two new plans to stop the spread of HIV are in effect in Marseilles, France, and Vancouver, British Columbia, according to reports in the December issue of the American Journal of Public Health. In Marseilles, sterile needles were provided at drugstores, needle exchange programs, and vending machines. A 1997 survey of 343 people obtaining the needles found that the vending machines were more often used by younger addicts who were less likely than others to have HIV or hepatitis. The lead author of the study, Dr. Yolande Obadia, director of the Regional Center for Disease Control of Southeastern France, believes the vending machines appear to attract a "hidden part of the injection-drug-user population." Meanwhile in Vancouver, researchers studying various marketing techniques to get people to purchase condoms found that in-store coupons for the prophylactics was the most effective system. While a widespread coupon distribution plan had little effect on condom sales, the University of Manitoba researchers found that offering discount coupons for condoms available for one day only inside the store resulted in more consumers buying the products.

Clinton: Cures for AIDS, Cancer Coming Next Century

"Clinton: Cures for AIDS, Cancer Coming Next Century" USA Today (12/28/99) P. 11A; Ullmann, Owen
President Clinton has predicted the next century will see an AIDS vaccine and cures for cancer. In an interview for CBS' "60 Minutes II," Clinton stated that a biological weapons attack is also possible in the 21st century. The president is currently proposing laws that would regulate the sale of prescription drugs over the Internet, to help prevent the sale of illegal medicines in the United States.

Nationline: Women and HIV

USA Today (12/28/99) P. 3A; Bacon, John
New research in the journal Nature reveal that HIV may infect women differently than men. This means a vaccine could be harder to make for women, who were shown in the study to be initially infected with multiple variants of HIV, while the men studied were infected by only one variant.

AIDS Linked to Infidelity in Dominican Republic

"AIDS Linked to Infidelity in Dominican Republic" Boston Globe Online (12/28/99) P. A2; Abel, David
The AIDS epidemic in the Dominican Republic is being fueled by infidelity among husbands. The Latin American country has one of the highest percentages of people with HIV, and married men with multiple sex partners are a contributing factor. Statistics from the Dominican Health Ministry show that at least 50 percent of men have cheated on their wives, and sexual education is not prevalent in the poor Caribbean nation. In addition, health officials revealed that 84 percent of teenagers surveyed did not believe they could contract HIV. Carmen Capell, the director of a health clinic in Santo Domingo that treats AIDS patients, said, "People [here] are just not conscious about the disease; they think they are invulnerable." Other factors affecting the HIV rate in Dominica are ignorance, prostitution, and the church's opposition to condoms. An estimated 2.8 percent of the 8 million Dominicans are infected with HIV, and that figure is expected to reach 3.3 percent of the population by 2005, with a growing number of infections among married women.

Re-Used Needles Didn't Result in Excess Infections, Health Officials Find

San Jose Mercury News (12/28/99); Krieger, Lisa M.
A California state investigation of a health technician who reused needles has found no excess rates of infection among the worker's patients. Blood tests found 80 infections of HIV, hepatitis B or C among 4,890 people whose blood was drawn by Elaine Giorgi, a former employee of SmithKline Beecham Clinical Laboratories in Palo Alto. The rate is comparable to that of the general population, the state Department of Health Services report found. The results show that the re-use of needles did not spark an outbreak of disease in the San Francisco area residents from whom Giorgi drew blood. However, San Jose attorney Steven Blick is suing SmithKline Beecham for emotional distress on behalf of all the potentially infected people. Testing was also voluntary, so the investigation did not include all of the possible 11,700 people who had their blood drawn by Giorgi from 1994 to 1996. Giorgi claims she washed the needles in disinfectant, reusing them because the type she preferred are more expensive than standard needles.

State of the Nation's Health: Needs Improvement

"State of the Nation's Health: Needs Improvement" Boston Globe Online (12/27/99) P. C1; Kong, Dolores
The results of "Healthy People 2000," a health status study for the United States, show that about 40 percent of the goals set 10 years ago for the year 2000 will not be met. In the past decade, the risk of death for Americans from cancer, heart disease, and homicide has declined; however, Native Americans, Hispanics, Asian Americans, and Pacific Islanders continue to have higher rates of diseases like diabetes and tuberculosis than the entire U.S. population. The goals for "Healthy People 2010" include ending the racial disparities in disease found throughout the United States. A final report about the new plan will be released January 25 by Secretary of Health and Human Services Donna E. Shalala and U.S. Surgeon General David Satcher.

Prisons Push AIDS Education

Reuters (12/27/99)
In Minnesota, the state Corrections Department has developed plans to educate inmates about AIDS. According to one health expert, many inmates are at risk because they used intravenous drugs before going to prison. Currently, Minnesota spends $81,000 on prison AIDS programs each year.

UK Blood Test May Transform HIV Treatment

Reuters (12/27/99)
A new HIV test developed by British researchers can help treat HIV patients more effectively and help save lives, according to new reports. The test can detect if HIV is hiding in the body and can also locate the waste products made from replication of the virus, which include circles of viral DNA that could be found in white blood cells. Doctors hope the test will lead to treatments that can halt the progression to AIDS.

stadtlander.com: HOME | HIV | BACK